Latest Breaking News On - ஆறு சிக்மா - Page 33 : comparemela.com

Share this article Share this article NEW YORK and BASEL, Switzerland, April 23, 2021 /PRNewswire/ Aruvant Sciences ( Aruvant ), a private company focused on developing gene therapies for rare diseases, today announced the appointment of Meghan Kelton, executive director, human resources (HR), and E. Blair Clark-Schoeb, senior vice president, communications, to the Aruvant leadership team.  Ms. Kelton s HR experience in gene therapy and Ms. Clark-Schoeb s public company and rare disease communications know-how will be critical as we take Aruvant to the next level, said Will Chou, M.D., chief executive officer of Aruvant. With the company in a growth phase, Ms. Kelton will focus on building out the technical, development and manufacturing functions and creating an inclusive environment needed to support an engaged workforce. Ms. Clark-Schoeb will lead our internal and external communications efforts, investor relations, media effort and work with the rare disease and sick

San diegoUnited statesDburns mcclellanInstagram aruvantE blair clark schoebMeghan keltonPrnewswire aruvant sciencesMedicines companyUniversity of scrantonAruvant sciencesHarvard universitySociety for human resource managementUniversity of pennsylvaniaSociety of healthcare innovationZyla life sciencesWill chou